These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37559511)

  • 1. Poststroke Depression: An Update.
    Robinson RG; Jorge RE; Starkstein SE
    J Neuropsychiatry Clin Neurosci; 2024; 36(1):22-35. PubMed ID: 37559511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-Stroke Depression: A Review.
    Robinson RG; Jorge RE
    Am J Psychiatry; 2016 Mar; 173(3):221-31. PubMed ID: 26684921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance and possibilities of therapy of post-stroke depression].
    Trusova NA; Levin OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9. Vyp. 2):60-67. PubMed ID: 31825392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterocyclics and selective serotonin reuptake inhibitors in the treatment and prevention of poststroke depression.
    Bhogal SK; Teasell R; Foley N; Speechley M
    J Am Geriatr Soc; 2005 Jun; 53(6):1051-7. PubMed ID: 15935033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality and poststroke depression: a placebo-controlled trial of antidepressants.
    Jorge RE; Robinson RG; Arndt S; Starkstein S
    Am J Psychiatry; 2003 Oct; 160(10):1823-9. PubMed ID: 14514497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The psychopharmacology of brain vascular disease/poststroke depression.
    Jones M; Corcoran A; Jorge RE
    Handb Clin Neurol; 2019; 165():229-241. PubMed ID: 31727214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis.
    Sun Y; Liang Y; Jiao Y; Lin J; Qu H; Xu J; Zhao C
    BMJ Open; 2017 Aug; 7(8):e016499. PubMed ID: 28775189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Electroacupuncture an Effective and Safe Treatment for Poststroke Depression? An Updated Systematic Review and Meta-Analysis.
    Wang X; Cai W; Wang Y; Huang S; Zhang Q; Wang F
    Biomed Res Int; 2021; 2021():8661162. PubMed ID: 34485527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-stroke depression: an update.
    Espárrago Llorca G; Castilla-Guerra L; Fernández Moreno MC; Ruiz Doblado S; Jiménez Hernández MD
    Neurologia; 2015; 30(1):23-31. PubMed ID: 22901370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is it safe to use antidepressants after a stroke?
    Rampello L; Battaglia G; Raffaele R; Vecchio I; Alvano A
    Expert Opin Drug Saf; 2005 Sep; 4(5):885-97. PubMed ID: 16111451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of poststroke depression: does prophylactic pharmacotherapy work?
    Salter KL; Foley NC; Zhu L; Jutai JW; Teasell RW
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1243-51. PubMed ID: 22554569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Citalopram for the Treatment of Poststroke Depression: A Meta-Analysis.
    Cui M; Huang CY; Wang F
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2905-2918. PubMed ID: 30201459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in antidepressants for treating post-stroke depression.
    Paolucci S
    Expert Opin Pharmacother; 2017 Jul; 18(10):1011-1017. PubMed ID: 28535081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notable efficacy of Shugan Jieyu capsule in treating adult with post-stroke depression: A PRISMA-compliant meta-analysis of randomized controlled trials.
    Wu T; Yue T; Yang P; Jia Y
    J Ethnopharmacol; 2022 Aug; 294():115367. PubMed ID: 35562090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of Sihogayonggolmoryeo-tang (Saikokaryukotsuboreito, Chai-Hu-Jia-Long-Gu-Mu-Li-Tang) for post-stroke depression: A systematic review and meta-analysis.
    Kwon CY; Lee B; Chung SY; Kim JW; Shin A; Choi YY; Yun Y; Leem J
    Sci Rep; 2019 Oct; 9(1):14536. PubMed ID: 31601868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Paroxetine for Poststroke Depression: A Meta-Analysis.
    Li L; Han Z; Li L; Han L; Yan B
    J Stroke Cerebrovasc Dis; 2020 May; 29(5):104664. PubMed ID: 32093988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological management of post-stroke depression: an update of the evidence and clinical guidance.
    Mortensen JK; Andersen G
    Expert Opin Pharmacother; 2021 Jun; 22(9):1157-1166. PubMed ID: 33530765
    [No Abstract]   [Full Text] [Related]  

  • 19. Does prestroke depression impact poststroke depression and treatment?
    Ried LD; Jia H; Cameon R; Feng H; Wang X; Tueth M
    Am J Geriatr Psychiatry; 2010 Jul; 18(7):624-33. PubMed ID: 20220578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and mechanism of acupuncture for ischemic poststroke depression: Study protocol for a multicenter single-blinded randomized sham-controlled trial.
    Lu H; Li M; Zhang B; Ren X; Meng L; Bai W; Wang L; Wang Z; Ding S; Gan Y; Zhang Z; Li P; Wang L; Meng Z; Zhao H; Wang F; Zhang C
    Medicine (Baltimore); 2019 Feb; 98(7):e14479. PubMed ID: 30762770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.